Susan Molineaux - Net Worth and Insider Trading

Susan Molineaux Net Worth

The estimated net worth of Susan Molineaux is at least $757 dollars as of 2024-04-28. Susan Molineaux is the PRESIDENT & CEO of Calithera Biosciences Inc and owns about 37,859 shares of Calithera Biosciences Inc (CALA) stock worth over $757. Susan Molineaux is also the Director of Geron Corp and owns about 0 shares of Geron Corp (GERN) stock worth over $0. Details can be seen in Susan Molineaux's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susan Molineaux has not made any transactions after 2023-05-01 and currently still holds the listed stock(s).

Transaction Summary of Susan Molineaux

To

Susan Molineaux Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susan Molineaux owns 5 companies in total, including Geron Corp (GERN) , Theravance Biopharma Inc (TBPH) , and Calithera Biosciences Inc (CALA) among others .

Click here to see the complete history of Susan Molineaux’s form 4 insider trades.

Insider Ownership Summary of Susan Molineaux

Ticker Comapny Transaction Date Type of Owner
GERN Geron Corp 2023-05-01 director
TBPH Theravance Biopharma Inc 2015-04-22 director
CALA Calithera Biosciences Inc 2021-11-10 director & PRESIDENT AND CEO
CYTT Cyteir Therapeutics Inc 2021-06-17 director
RPTX Repare Therapeutics Inc 2023-06-08 director

Susan Molineaux Latest Holdings Summary

Susan Molineaux currently owns a total of 2 stocks. Among these stocks, Susan Molineaux owns 37,859 shares of Calithera Biosciences Inc (CALA) as of November 10, 2021, with a value of $757 and a weighting of 100%. Susan Molineaux also owns 0 shares of Geron Corp (GERN) as of May 1, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Susan Molineaux

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CALA Calithera Biosciences Inc 2021-11-10 37,859 0.02 757
GERN Geron Corp 2023-05-01 0 3.79 0

Holding Weightings of Susan Molineaux


Susan Molineaux Form 4 Trading Tracker

According to the SEC Form 4 filings, Susan Molineaux has made a total of 2 transactions in Calithera Biosciences Inc (CALA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Calithera Biosciences Inc is the acquisition of 5,000 shares on November 10, 2021, which cost Susan Molineaux around $85,000.

According to the SEC Form 4 filings, Susan Molineaux has made a total of 1 transactions in Geron Corp (GERN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Geron Corp is the sale of 35,000 shares on May 1, 2023, which brought Susan Molineaux around $86,800.

Insider Trading History of Susan Molineaux

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Susan Molineaux Trading Performance

GuruFocus tracks the stock performance after each of Susan Molineaux's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Susan Molineaux is -24.58%. GuruFocus also compares Susan Molineaux's trading performance to market benchmark return within the same time period. The performance of stocks bought by Susan Molineaux within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Susan Molineaux's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Susan Molineaux

Average Return

-15.26%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.91 -24.58 -5.32 -15.26 -59.8 -67.38
Relative Return to S&P 500(%) -1.28 -24.2 -3.62 -10.67 -69.09 -77.65

Susan Molineaux Ownership Network

Ownership Network List of Susan Molineaux

No Data

Ownership Network Relation of Susan Molineaux


Susan Molineaux Owned Company Details

What does Geron Corp do?

Who are the key executives at Geron Corp?

Susan Molineaux is the director of Geron Corp. Other key executives at Geron Corp include EVP & Chief Financial Officer Michelle Robertson , EVP & Chief Legal Officer Scott Alan Samuels , and director & Chief Executive Officer John A Scarlett .

Geron Corp (GERN) Insider Trades Summary

Over the past 18 months, Susan Molineaux made 1 insider transaction in Geron Corp (GERN) with a net sale of 35,000. Other recent insider transactions involving Geron Corp (GERN) include a net sale of 1,340,000 shares made by John A Scarlett , a net sale of 400,000 shares made by Olivia Kyusuk Bloom , and a net sale of 384,719 shares made by Andrew J Grethlein .

In summary, during the past 3 months, insiders sold 0 shares of Geron Corp (GERN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,194,719 shares of Geron Corp (GERN) were sold and 13,186 shares were bought by its insiders, resulting in a net sale of 2,181,533 shares.

Geron Corp (GERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Geron Corp Insider Transactions

No Available Data

Susan Molineaux Mailing Address

Above is the net worth, insider trading, and ownership report for Susan Molineaux. You might contact Susan Molineaux via mailing address: C/o Calithera Biosciences, Inc., 343 Oyster Point Blvd., Suite 200, South San Francisco Ca 94080.

Discussions on Susan Molineaux

No discussions yet.